-
The principal purpose of this clinical study was to evaluate the efficacy of gemcitabine relative to a clinical standard therapy, pegylated liposomal doxorubicin (PLD) in women with ovarian cancer relapsing within a year of primary treatments.
-
Sentinel node localization and sampling has become a standard practice in the evaluation of regional nodal status for patients with breast cancer and cutaneous melanoma.
-
-
One hundred and twenty subjects with symptoms of idiopathic detrusor overactivity (OAB) were recruited to evaluate the efficacy of reflexology compared to nonspecific foot massage.
-
In a previous Clinical Alert, the risk of uterine rupture in patients attempting vaginal birth after cesarean sections (VBACs) was addressed when it appeared that there was a distinct downturn in the amount of VBACs being done in the USA.
-
The Women's Health Initiative investigators reported health outcomes at 3 years after the estrogen-progestin arm of the clinical trial was canceled.
-
In this issue: Does erythropoietin worsen cancer death rates? Most hypothyroid patients can be replaced with levothyroxine alone without additional T3. Does aggressive control in type 2 diabetes save lives?
-
-
At a time when surgery centers are facing Medicare changes and proposed freezes that are causing a seemingly endless financial struggle, a standoff that developed between a private payer and a surgery center chain in Ohio is causing some centers to call foul.
-
Andrew Cuomo, the New York state attorney general, is going to sue UnitedHealth Group and four of its subsidiaries, including Ingenix, on allegations that they defrauding consumers by manipulating reimbursement rates, according to the American Hospital Association (AHA).
